Search results for “Human papillomavirus” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 2,214 patents, we discovered top 456 key players by total patent application. GlaxoSmithKline Biologicals SA, Merck & Co., Inc., PreTect AS are dominant in this area. They take 9.44% of the total patent filing.
Belgium
Patent: 80
New Jersey, United States
Patent: 67
Buskerud, Norway
Patent: 62
Fujian Sheng, China
Patent: 49
New Jersey, United States
Patent: 45
California, United States
Patent: 42
Ontario, Canada
Patent: 23
New Jersey, United States
Patent: 23
California, United States
Patent: 22
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 54 patents, we discovered top 13 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Agenovir Corp., Abviris Deutschland GmbH are active in this area.
STARTUP
France
Patent: 23
STARTUP
California, United States
Patent: 7
STARTUP
Thüringen, Germany
Patent: 4
STARTUP
California, United States
Patent: 3
STARTUP
Simple Healthkit, Inc.
California, United States
Patent: 3
STARTUP
California, United States
Patent: 3
STARTUP
Eterna Therapeutics LLC
New York, United States
Patent: 2
STARTUP
Hubei Sheng, China
Patent: 2
STARTUP
Gyeonggi-do, South Korea
Patent: 2
STARTUP
Guangdong Sheng, China
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 683 patents applied in the last 5 years. We discover 284 most active companies in this area. The fast-growing Merck Sharp & Dohme LLC, Shenzhou Cell Engineering Co Ltd., Regeneron Pharmaceuticals, Inc. take 7.47% of patent filing during this period.
New Jersey, United States
Patent: 19
Beijing Shi, China
Patent: 17
New York, United States
Patent: 15
Pennsylvania, United States
Patent: 15
United States
Patent: 15
Austria
Patent: 12
Clackmannanshire, United Kingdom
Patent: 11
Washington, United States
Patent: 11
United States of America
United States
Patent: 11
New Jersey, United States
Patent: 11
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 683 patents in last 5 years, we discover 221 new entrants. Shenzhou Cell Engineering Co Ltd., Regeneron Pharmaceuticals, Inc., SELO MEDICAL GmbH are the most active new entrants in this area.
Beijing Shi, China
Patent: 17
New York, United States
Patent: 15
United States
Patent: 15
Washington, United States
Patent: 11
New Jersey, United States
Patent: 11
Zhejiang Sheng, China
Patent: 10
Singapore
Patent: 9
Osaka-fu, Japan
Patent: 9
Massachusetts, United States
Patent: 7
Jiangsu Sheng, China
Patent: 6
Research Institutions
Order by:
Innovation Intensity
With the analysis among 675 patents, we discovered top 99 universities and scientific research institutions by total patent application. Xiamen University, The Johns Hopkins University, University of Cape Town are dominant in this area. They take 22.96% of the total patent filing.
Fujian Sheng, China
Patent: 59
United States
Patent: 47
South Africa
Patent: 41
New York, United States
Patent: 28
Texas, United States
Patent: 20
United States
Patent: 14
Queensland, Australia
Patent: 12
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 11
Massachusetts, United States
Patent: 8
Beijing Shi, China
Patent: 8
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: